The relationships between asthma control, daytime sleepiness, and quality of life among children with asthma: a path analysis by Li, Zheng et al.
The relationships between asthma control, daytime sleepiness,
and quality of life among children with asthma: a path analysis
Zheng Li, MPH1, I-Chan Huang, PhD1,2,*, Lindsay Thompson, MD, MS3, Sanjeev Tuli, MD,
Med3, Shih-Wen Huang, MD3, Darren DeWalt, MD, MPH4, Dennis Revicki, PhD5, and
Elizabeth Shenkman, PhD1,2
1Department of Health Outcomes and Policy, College of Medicine, University of Florida,
Gainesville, FL
2Institute for Child Health Policy, College of Medicine, University of Florida, Gainesville, FL
3Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL
4Department of Medicine, School of Medicine, University of North Carolina-Chapel Hill
5Outcomes Research, United BioSource Corporation, Bethesda, MD
Abstract
Objectives—We aimed to examine the relationships between asthma control, daytime
sleepiness, and asthma-specific health-related quality of life (HRQOL) among children with
asthma. Path analyses were conducted to test if daytime sleepiness can mediate the effect of
asthma control status on asthma-specific HRQOL.
Methods—160 dyads of asthmatic children and their parents were collected for analyses. The
Asthma Control and Communication Instrument (ACCI) was used to categorize adequate and poor
asthma control status. The Cleveland Adolescent Sleepiness Questionnaire (CASQ) was used to
measure children’s daytime sleepiness, including sleep in school, awake in school, sleep in
evening, and sleep during transport. The Patient-Reported Outcomes Measurement Information
System (PROMIS) Asthma Impact Scale was used to measure asthma-specific HRQOL.
Results—Poorly controlled asthma was associated with daytime sleepiness and impaired asthma-
specific HRQOL. Asthma control status was directly associated with asthma-specific HRQOL
(P<.05), whereas sleep in school and sleep in evening domains of daytime sleepiness significantly
mediated the relationship between poor asthma control and impaired HRQOL (P<.01).
Conclusions—Asthma control status was associated with pediatric asthma-specific HRQOL,
and the association was significantly mediated by daytime sleepiness. Healthcare providers need
to address pediatric sleep needs related to poor asthma control to reduce the impact on HRQOL.
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1. Introduction
Asthma is one of the most prevalent pediatric chronic diseases in the United States, affecting
an estimated 7 million (approximately 10%) of children in 2007 [1,2]. Although effective
medication is available to treat pediatric asthma, many children are still living with
persistent asthma symptoms, including shortness of breath, coughing, wheezing, nighttime
awakening, and sleeping difficulties [3,4]. Underuse of oral corticosteroids and overuse of
rescue medicine are important issues contributing to poorly controlled asthma [5,6].
Previous studies have shown that the prevalence of poorly controlled asthma status is
various (37%–80%) among children with asthma, depending on different study designs, age
of children, severity of asthma, and other factors [7–13]. For example, one study reported
that 46% of the asthmatic children who used inhaled corticosteroids had poorly controlled
asthma [13]. Numerous studies have illustrated that poor asthma control in children was
associated with activity intolerance leading to impaired functional status, such as attention
difficulty [14], poor sleep quality [14], poor peer relationships [15], absence from school
[16], academic underperformance [16], and low asthma-specific health-related quality of life
(HRQOL) [17,18].
The relationship between asthma symptoms and HRQOL is well-established. A systematic
review found that asthmatic children with poor control were more likely to experience
poorer HRQOL compared to those with adequate control [19]. Using the Pediatric Quality
of Life Inventory to measure generic HRQOL, a study found that children with asthma had
considerable impaired physical, emotional, social, and school functioning compared to that
of healthy children [20]. In addition, a study using the Pediatric Asthma Quality of Life
Questionnaire to measure asthma-specific HRQOL reported that HRQOL was significantly
impaired in the domains of symptoms, activity limitation, and overall HRQOL among
children with unstable asthma control compared to children with stable asthma control [21].
Asthmatic children are more likely to report sleep concerns than healthy children [22–24].
Airway resistance greatly increases at nighttime when people sleep, and this issue is
significant for asthmatic children leading to exacerbated coughing, wheezing, and sleeping
difficulties [25]. Although 25% of the general US population of children experienced
nighttime sleep difficulties [26], 34% to 40% of asthmatic children experienced nocturnal
awakening [27,28]. Asthmatic children with poor asthma control status had more nocturnal
awakening per week compared to children with adequate asthma control status (66% vs
14%) [29]. Children with nighttime sleep concerns had more difficulties in growth,
development, and functional status, including attention difficulties, daytime sleepiness, poor
school performance, missed school days [30, 31], and psychologic dysfunction (i.e., anxiety,
depression) [32–34]. Previous pediatric studies have separately investigated the relationships
between asthma control and HRQOL [15,16,19–21], between sleep concerns and HRQOL
[30,32–34] and between asthma control and sleep concerns [22–24], yet the complex
mechanism among asthma control status, sleep concerns, and HRQOL has not been
explored. Sleep concerns including nighttime sleep and daytime sleepiness are equally
important to asthmatic children, but the majority of the studies focus on nighttime sleep
rather than daytime sleepiness difficulties [23,24,26–28,30].
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The purpose of our study was to examine the relationships among asthma control status,
daytime sleepiness, and asthma-specific HRQOL in asthmatic children. Instead of viewing
sleep concerns as a nuisance variable, we hypothesized that daytime sleepiness is an
important factor to mediate the relationship between asthma control status and HRQOL.
Specifically we used path analysis methodology to quantify the direct and indirect effects of
asthma control on asthma-specific HRQOL through the mechanism of daytime sleepiness
[35].
2. Methods
2.1 Population and data collection
This cross-sectional study used data collected from children who were previously diagnosed
with asthma between the ages of 8 and 17 years and their parents. Exclusion criteria were
parents and children who had any concurrent medical or psychiatric conditions that may
have affected the completion of the survey, children who had asthma-like symptoms but
were not diagnosed as having asthma, or parents and children who were not able to read and
speak English. After the University of Florida’s institutional review board approved the
protocol, we recruited 160 asthmatic children and their parents between June 2010 and
August 2011 who visited the University of Florida Pediatric Primary Care at Gerold L.
Schiebler Children’s Medical Services Center and Tower Square, the Pediatric After Hours
Clinic, the Pediatric Allergy Clinic, or the Pediatric Pulmonary Clinic. During the scheduled
clinical visit, children filled out the questionnaires measuring daytime sleepiness and
asthma-specific HRQOL, and parents filled out the questionnaire measuring asthma control
status and sociodemographic characteristics.
2.2 Measurement and instruments
Three well-validated instruments, Asthma Control and Communication Instrument (ACCI)
[36], Cleveland Adolescent Sleepiness Questionnaire (CASQ) [37], and National Institutes
of Health Pediatric Patient-Reported Outcomes Measurement Information System
(PROMIS) were used to measure asthma control status [38], daytime sleepiness, and
asthma-specific HRQOL, respectively.
The ACCI is comprised of 12 items measuring 5 domains of asthma status, including
perception of asthma concern (1 item), asthma control (5 items), direction of symptoms (1
item), short-term care (3 items), and adherence to asthmatic medication (1 item). In addition,
one open-ended question was used to collect the family’s needs for assistance with asthma
management [36]. The ACCI has demonstrated good psychometric properties, including
internal consistency reliability, convergent and discriminatory validity, and known-group
validity [36]. In compliance with the National Asthma Education Prevention Program
(NAEPP) Expert Panel Report 3 (EPR-3) for measuring asthma control status, 5 items
(symptoms, nighttime awakening, the use of short-acting β2 agonists for quick relief of
symptoms, limitations to normal activities, and asthma attack frequency) were included in
this instrument. For an individual patient, we classified the answer from each item into well-
controlled, not well-controlled, and very poorly controlled. Consistent with the NAEPP
EPR-3, the overall control status of an individual patient is determined by the most severe
response among the 5 items [39]. That is, each patient was assigned to the adequate control
group (in line with EPR-3’s well-controlled) if he or she endorsed all of the 5 items as well-
controlled; otherwise, a patient was assigned to the poor control group (in line with EPR-3’s
not well-controlled and very poorly controlled) [36,39].
The CASQ is comprised of 16 items measuring excessive daytime sleepiness and alertness
in adolescents, including 4 domains of sleep in school, awake in school, sleep in evening,
and sleep during transport [37]. In contrast with other self-reported sleep measures for
Li et al. Page 3













pediatric populations, the CASQ focuses on daytime sleepiness symptoms and does not
include any questions measuring nighttime sleep concerns or symptoms of sleeping
difficulties. The CASQ has demonstrated acceptable internal consistency reliability with a
Cronbach α of 0.89 and a satisfactory convergent and discriminatory validity by comparing
the CASQ scores to the scores of 2 legacy daytime sleepiness measures, the Pediatric
Daytime Sleepiness Scale and School Sleep Habits Survey [37]. Because the CASQ
measures children’s sleepiness issues during and after school, it captures the full spectrum of
children’s daytime activities relevant to sleepiness. Our study specifically examined which
domains of daytime sleepiness were significantly related to asthma control and asthma-
related HRQOL. The response categories for each item were never, rarely, sometimes, often,
and almost every day. The domain score was calculated by summing individual item scores
within the domain, with higher scores indicating more daytime sleepiness concerns.
The National Institutes of Health’s PROMIS pediatric scales were designed to measure
important domains of patient-reported outcomes, including physical function, depression,
anxiety, fatigue, mobility, pain, peer relationship, and asthma impact [38]. Our study used
the asthma impact domain (8 items) to measure asthma-specific HRQOL in children. The
PROMIS Asthma Impact Scale has demonstrated good construct validity based on item
response theory to assess the unidimensionality and the satisfactory convergent and
discriminatory validity by comparing its scale score to the Pediatric Quality of Life
Inventory asthma symptoms scale score [38,40]. The response categories for each item are
never, almost never, sometimes, often and almost always. The domain score was calculated
by item response theory, with higher scores indicating greater impairment in HRQOL.
2.3 Statistical analysis
Descriptive analyses were performed to investigate the distributions of demographic
characteristics among 160 dyadic participants based on mean and standard deviation (SD) of
child’s and parent’s age, child’s gender, race or ethnicity, presence of comorbid conditions
(e.g., high blood pressure, attention deficit hyperactivity disorder, or other learning
disabilities), asthma control status, and parent’s education level, race or ethnicity, and family
incomes. In addition, mean, median, and SD, and floor and ceiling effects were reported for
individual domains of the CASQ and the PROMIS instruments. We defined ceiling and
floor effects as the percentage of the participants who reported the highest and lowest scores
for each domain, respectively.
Regression analyses and t tests were performed to examine the bivariate and multivariate
relationships among asthma control, daytime sleepiness, and asthma-specific HRQOL. Six
linear regression models were conducted using asthma-specific HRQOL as the outcome
variable. Different independent variables were included in different regression models,
including asthma control in model 1, sleep in school domain of the CASQ in model 2,
awake in school domain of the CASQ in model 3, sleep in evening domain of the CASQ in
model 4, sleep during transportation domain of the CASQ in model 5, and all 4 domains of
the CASQ in model 6. Child’s age and gender as well as parental age, race or ethnicity,
education background, and family income were adjusted in each regression model.
Finally, path analyses were performed to examine the direct effect of asthma control on
asthma-specific HRQOL, and the indirect effect of asthma control status on asthma-specific
HRQOL through the 4 domains of daytime sleepiness as mediators. We used structural
equation modeling (SEM) to quantify the direct and indirect effects of asthma control on
asthma-specific HRQOL. The unique feature of SEM methodology is the ability to
simultaneously estimate the regression coefficients for a hypothesized complex pathway
between the variables of interest. In SEM we assumed that the constructs of the 4daytime
sleepiness domains and asthma-specific HRQOL were latent and that they would be
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estimated by the indicators (i.e., items) of the instruments. Two SEMs were performed
consisting of a simple model examining the relationship between asthma control and
asthma-specific HRQOL and a full model examining the relationships among asthma
control, daytime sleepiness, and asthma-specific HRQOL. The full SEM tested all pathways
among asthma control, all domains of daytime sleepiness, and asthma-specific HRQOL. We
used the root mean square error of approximation (RMSEA) and comparative fit index (CFI)
to indicate the adequacy of the model fit. The possible values of RMSEA and CFI were
between 0 and 1, and the values of RMSEA <0.08 and CFI >0.9 were considered as a
satisfied model fit [41,42].
In our study, Mplus 6 (Muthen and Muthen, Los Angeles, CA) was used for path analyses,
and SAS 9.2 (SAS Institute Inc., Cary, NC) was used for the rest of the analyses.
3. Results
3.1 Participant characteristics
Table 1 shows the participant characteristics. For children (N=160), the mean age was 11.6
years (SD, 2.4); the majority were boys (59.4%) and of black descent (55.6%). For parents,
the mean age was 40.1 years (SD, 9.6), and the majority were of black descent (54.4%) and
had educational background of some college or an Associate degree (41.9%) or above.
Approximately 68% of children reported at least one comorbid conditions, and 51.9% of
children had poor asthma control status.
3.2 Measurement of daytime sleepiness and asthma-specific HRQOL
Table 2 shows the domain scores of daytime sleepiness and asthma-specific HRQOL. All
domain scores of daytime sleepiness were slightly skewed to better outcomes; however, the
scores in asthma-specific HRQOL were slightly skewed to worse outcomes. Ceiling effects
were not significant (<10% of the participants) in all domains; however, the floor effects
were significant (>30% of the participants) in the sleep in school domain.
3.3 Bivariate associations between asthma control, daytime sleepiness, and asthma-
specific HRQOL
Table 3 shows the bivariate associations between asthma control on the 4 domains of
daytime sleepiness and asthma-specific HRQOL, respectively, based on the t tests. In
general children with poor asthma control status were significantly associated with greater
daytime sleepiness in all domains (P<.01) (except the awake in school domain), and poorer
asthma-specific HRQOL (P<.01) than those with adequate control status.
3.4 Multivariate association between asthma control, daytime sleepiness, and asthma-
specific HRQOL
Table 4 shows the relationships between asthma control, daytime sleepiness, and asthma-
specific HRQOL based on regression analyses. Model 1 revealed that poor asthma control
status was significantly associated with impaired asthma-specific HRQOL after adjusting for
covariates (P<.001). Models 2, 3, 4, and 5 showed 3 domains of daytime sleepiness (sleep in
school, sleep in evening, and sleep during transport) were significantly associated with
impaired HRQOL (P<.01). With the inclusion of all 4 daytime sleepiness domains, model 6
showed that only sleep in school and sleep in evening domains were significantly associated
with impaired asthma-specific HRQOL (P<.01). This finding suggests that the significant
association of sleep during transport with asthma-specific HRQOL was explained by the
domains of sleep in school and sleep in evening.
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3.5 Direct and indirect effects of asthma control on asthma-specific HRQOL
Fig. 1A shows the direct effect of asthma control on asthma-specific HRQOL without
including daytime sleepiness in the SEM analysis. The estimated magnitude of direct effect
was 0.425 (P<.01), and the model fit was marginally satisfied with RMSEA of 0.08 and
unsatisfied with CFI of 0.865.
Fig. 1B shows the mediating effects of daytime sleepiness on the relationship between
asthma control and asthma-specific HRQOL based on the full SEM path analytic model.
The model fit was satisfied with RMSEA of 0.069 and CFI of 0.902. However, the direct
effect of asthma control on asthma-specific HRQOL was decreased from 0.425 (P<.01) (Fig.
1A) to 0.242 (P<.01) (Fig. 1B). Although poor asthma control status was significantly
associated with impaired asthma-specific HRQOL, the relationships were partially explained
by the mediating effects of daytime sleepiness. Approximately 43% of the total variance in
the asthma control-HRQOL association was explained by the indirect effects of daytime
sleepiness. This finding implies that daytime sleepiness plays an important role in mediating
the relationship between asthma control status and asthma-specific HRQOL.
Specifically, 2 significant pathways were identified suggesting the indirect effects of asthma
control on asthma-specific HRQOL through 2 daytime sleepiness domains. The first
pathway was asthma control status on asthma-specific HRQOL through sleep in school
(magnitude, 0.067; P<.05). The second pathway was asthma control status on asthma-
specific HRQOL through sleep in evening (magnitude, 0.084; P<.05).
4. Discussion
To our knowledge, our study is among the first to articulate the effect of daytime sleepiness
on the relationship between asthma control status and asthma-specific HRQOL in asthmatic
children. We found poorly controlled asthma was associated with daytime sleepiness and
impaired asthma-specific HRQOL. However, we extend the literature and suggest that,
although poor asthma control status was directly and significantly associated with impaired
asthma-specific HRQOL, 2 daytime sleepiness domains (sleep in school and sleep in
evening) significantly mediated the aforementioned direct relationship. These 2 sleepiness
domains cover the important daily activity difficulties that asthmatic children face yet rarely
are discussed in the literature.
The NAEPP EPR-3 guidelines emphasize the importance of monitoring and managing
asthma control status [39]. Poor asthma control in which children did not adhere to effective
treatment plans and endured acute asthma attacks and symptom exacerbation is related to
significant HRQOL impairment [43]. Indeed, it appears that a substantial part of the
relationship between asthma control and HRQOL is a consequence of sleep concerns. This
insight emphasizes the importance of assessing nighttime symptoms and daytime sleepiness
by clinicians as an important element of managing pediatric asthma.
Conceptually sleepiness difficulties during daytime might be indicative of sleep difficulties
or poor nighttime sleep quality due to asthma symptoms. We partially support this
hypothesis because the ACCI includes one item (How many nights did asthma wake him/her
up?) to measure nocturnal awakening and nighttime sleep disturbance [44], and we found
that children with more nocturnal sleep difficulties experienced more daytime sleepiness
compared to children with less nocturnal sleep difficulties. For children who experience
more nighttime sleep difficulties together with sleepiness during and after school, alertness
and concentration in class will be suboptimal, and ultimately their physical, mental, and
social functioning will be affected.
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To help identify sleep difficulties in children with poor health conditions such as asthma, it
is critical to use conceptually sound and psychometrically tools to appropriately measure
nighttime and daytime sleepiness-related difficulties. Although electrophysiologic
techniques such as electroencephalography and polysomnography are regarded as the gold
standard to measure sleep quality, the use of self-report instruments provides supplementary
information. Buysse et al [45] developed PROMIS sleep disturbance and sleep-related
impairments item banks which could potentially be used to assess general sleep difficulties
in clinical settings. Unfortunately, the sleep-related item banks were not designed for
children and youth. Other instruments such as the Pittsburgh Sleep Quality Index [46] and
Insomnia Severity Index [47] are restricted to a narrow scope of sleep difficulties and
merely are designed for adults. The Pittsburgh Sleep Quality Index identifies 7 important
domains, including sleep latency, sleep duration, sleep disturbances, and subjective sleep
quality [46]. The Insomnia Severity Index focuses on difficulties with sleep onset, with sleep
maintenance, with early awakening, and satisfaction with sleep pattern [47].
Identifying appropriate therapeutic strategies to address sleep difficulties in asthmatic
children is neglected in most clinical settings due in part to the complex mechanisms or
unknown effects. Appropriate use of controller medication is the one of the resolutions for
sleep difficulty among asthmatic children [48]. Some children may benefit from
environmental allergen reduction such as exposure to dust mites in bed [25]. A clinical trial
showed that continuous positive airway pressure (CPAP) might improve sleep apnea and
daytime sleepiness [49]. Unfortunately, this study was conducted in adults rather than in
pediatric populations. Interventions based on physiologic, psychologic, and behavioral
perspectives [50] might be useful to address nighttime sleep difficulties and daytime
sleepiness issues faced by children who frequently have poor asthma control status.
Some limitations should be noted in the interpretations of the findings. First our participants
were recruited from a single academic institution where their characteristics may be
different from the general population. Second our study focused on the pathways in which
poorly controlled asthma influenced HRQOL through poor daytime sleepiness. We did not
take into account and test other potential mediators such as allergic rhinitis and exercise-
induced bronchoconstriction [51] in the path analysis. Daytime sleepiness only explained
part of indirect effect (43%) between asthma control and asthma-specific HRQOL, and we
believe these aforementioned factors might have contributed to the pathway. Third we
decided a priori that the parental report rather than the child’s report should be used for
asthma control assessment. The rationale is that some items measuring asthma control are
related to medication use, and we believe parents generally understand the types of
medication more appropriately than adolescents. As a caregiver in the family, a parent also
understands their child’s asthma symptoms. In contrast, adolescents more appropriately
perceive their HRQOL and daytime sleepiness difficulties than parents. Previous studies
have shown that both parents and children were likely to overreport adherence to asthma
medication than the use of objective measures such as asthma inhaler canister weight checks
and electronic canister measures [52,53]. Interestingly, medication use reported by parents
and children was not significantly different [52,53]. Because few studies have investigated
the discrepancy in asthma control status between parent proxy report and adolescent self-
report, further studies are needed to better understand the validity of different asthma control
measures. Fourth we were only able to collect spirometry data (forced expiratory volume in
1 second and forced vital capacity) from 5% of the participants. Spirometry measurement
provides important information regarding a patient’s asthma status, especially lung function.
However, collecting spirometry data from pediatric patients is challenging. A recent review
article emphasized the importance of collecting spirometry data but recognized that few
studies have used both spirometry and patient-reported outcomes information to measure
asthma control status due to the practical challenges [54]. Finally the pathway of asthma-
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control daytime sleepiness–HRQOL was based on a cross-sectional design, which does not
provide information on causation. A longitudinal study design with multiple end point
measurements is needed to establish the temporal sequence and confirm the causal
relationship. In addition, the use of a longitudinal study design would capture asthma
exacerbation or deterioration of asthma control status and answer whether or not the change
of asthma control status is associated with daytime sleepiness and HRQOL. Although we
did not specifically collect information on asthma exacerbation or deterioration of asthma
control status, the ACCI used in our study did include one item measuring the current use of
rescuer medication (i.e., short-acting β2 agonists and oral corticosteroid burst) which is
related to asthma exacerbation. Our additional analysis based on this single item of rescue
medication also found the rescue medication use was significantly associated with the
excess daytime sleepiness.
In conclusion, our study established the linkage among poorly controlled asthma, daytime
sleepiness, and impaired asthma-specific HRQOL in asthmatic children. Poor asthma
control status was associated with impaired asthma-specific HRQOL, and this association
was significantly mediated by daytime sleepiness difficulties. Two daytime sleepiness
concerns (sleep in school and sleep in evening) significantly mediated the relationship of
asthma control with asthma-specific HRQOL. Clinicians are encouraged to screen and
manage daytime sleepiness as an avenue to improve HRQOL among children with poorly
controlled asthma.
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Fig. 1 (A and B)
Direct effects of asthma control on asthma-specific health-related quality of life (A).
*P<.05; ** P<.01; *** P<.001.
Comparative fit index, 0.865.
Root mean square error of approximation, 0.080.
Squares indicate observed constructs.
Ellipses indicate latent constructs.
Mediating effects of daytime sleepiness on the relationships of asthma control and asthma-
specific health-related quality of life (B).
Indirect effect (asthma control on asthma-specific health-related quality of life (HRQoL)
through sleep in school), 0.067*.
Indirect effect (asthma control on asthma-specific HRQoL through awake in school), 0.001.
Indirect effect (asthma control on asthma-specific HRQoL through sleep in evening),
0.084*.
Indirect effect (asthma control on asthma-specific HRQoL through sleep during transport),
0.031.
Total effects (direct plus indirect effects): 0.425***.
*P<.05; ** P<.01; *** P<.001.
Comparative fit index, 0.902.
Root mean square error of approximation, 0.069.
Squares indicate observed constructs.
Ellipses indicate latent constructs.
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Table 3
Bivariate analyses of asthma control with daytime sleepiness and with asthma-specific health-related quality
of life.
Adequate control Poor control Difference t value
Sleep in school† 10.48 20.78 −10.30 −3.25**
Awake in school† 43.87 48.73 −4.87 −1.32
Sleep in evening† 27.86 40.65 −12.79 −3.59***
Sleep during transport† 19.30 34.53 −15.23 −4.03***
Asthma-specific HRQOL‡ 48.13 54.96 −6.83 −5.41***






Higher scores indicate greater daytime sleepiness.
‡
Higher scores indicate worse asthma-specific HRQOL.
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